Lead diagnostic triage and Individualized Commercialization Plans (S4, S5): lead the structured triage of each selected company across technical development, market validation, business formation, regulatory status, and capital readiness, anchored to the TRL, MRL, CRL, and IRL readiness frameworks; coordinate founder and team assessments, including the Start-up Entrepreneur Competency Model and professionally administered behavioral assessments; and co-develop each company's ICP with the company and its lead advisor, including gap diagnosis, baseline readiness scores, the 90-day/6-month/12-month milestone schedule, tranche-linked budget, named resource and advisor assignments, and explicit investor-readiness targets. Support governance and milestone accountability (S7): serve on the commercialization-support review committee (chaired by the Executive Director, with a Strategic Board designee and RTI observer), which verifies milestones, confirms continued research participation, and authorizes tranche releases independently of delivery staff; prepare complete, auditable milestone-verification materials and present progress against agreed milestones at each checkpoint; update each company's support plan at checkpoints based on progress data; and prepare and run the structured re-engagement review process for companies whose ICP implementation stalls, with decision authority resting with the Executive Director.